While the healthcare sector generally continues to look for direction, pharmaceutical stocks are the clear leaders, with Merck standing out as one of the group’s best performing companies. Over the past few months, the stock has demonstrated a remarkable ability to leverage multi-week consolidation phases to deliver clean breakouts and sustained gains. Merck has been quietly digesting the latest moves since February, and it’s worth paying close attention to how its structure is taking shape. The developing base now resembles a potential inverted head and shoulders pattern. This is one of the more reliable bottoming formations in technical analysis. As with any pattern of this type, patience is key. Additional consolidation below the noted resistance level will help further define the right shoulder and strengthen the overall setup before attempting the breakout. From a risk-reward perspective, this trade is well-defined. A break above $124 will officially trigger the pattern and open the door to an upside target near $135, which would show meaningful potential given current levels. Equally important is timing. Merck does not report earnings until April 30th, so this setup is a potentially valuable triggering opportunity. Looking back at the quarterly chart to the mid-1980s, the recent rally in recent months could be the early stages of an eventual long-term recovery. Here we present various instances over the past nearly 40 years (marked in red) where Merck endured significant declines over months or even years, stabilized, and eventually broke through a major downtrend line. What followed these breakouts was more than just a gradual rally. We’re talking about powerful, long-lasting enhancements that will last for decades. This has happened four times, most recently from 2009 to early 2024. If history is any guide, and with a chart this clean it’s hard to ignore, Merck could not only regain its former highs of just over $134, but could rise well above that level over time. While the short-term setting we have outlined is compelling in itself, the long-term context adds another dimension entirely. So how do we know if this rally has more room? We’ve described a very short-term bullish pattern and an attractive long-term quarterly picture. Now let’s look at a more intermediate perspective through a weekly log chart. From this perspective, the most important thing to watch going forward is how Merck will behave around the rising weekly moving average. Over the past few years, the cluster of moving averages has consistently acted as support when stocks were at their best. The line was trending up and when a stock had momentum, the price respected it too. Once the momentum weakened, the stock reversed and the same line turned into resistance on the way down. A textbook example of this dynamic played out from early 2024 to early 2025. Therefore, for this rally to prove itself and expand further meaningfully, we need to see these lines return to a supporting role. That doesn’t mean Merck has to be above all lines all the time. But most of the time you need to respect them. Disclosure: None. All opinions expressed by CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, its parent or affiliates, and may have been previously disseminated on television, radio, the Internet, or another medium. This content is provided for informational purposes only and does not constitute financial, investment, tax, or legal advice or a recommendation to purchase any securities or other financial assets. The content is general in nature and does not reflect your unique personal circumstances. The above may not be appropriate for your particular situation. Before making any financial decisions, you should strongly consider seeking the advice of your own financial or investment advisor. Click here for full disclaimer.
